Healthcare innovation equities are languishing, but it could time for one of the most well-known names in the group to turn around, and that could be constructive for select exchange traded funds, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). In a note to clients on Friday,...